Plasma-based circulating tumour DNA and cell-free DNA testing.
Plasma-based testing analyses circulating tumour DNA when tissue is limited, inaccessible or no longer representative of current disease. It complements, rather than replaces, tissue-based analysis.
Documented capability
Targeted plasma next-generation sequencing
ESR1 mutation testing by droplet digital PCR
Cell-free DNA assay development and validation experience
Interpretation of plasma findings in the context of tissue results and clinical course
This page is informational. It does not accept requests, samples, patient data or
genomic files, and provides no result lookup.